BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

549 related articles for article (PubMed ID: 18174685)

  • 1. Combined pH-metry/impedance monitoring increases the diagnostic yield in patients with atypical gastroesophageal reflux symptoms.
    Bajbouj M; Becker V; Neuber M; Schmid RM; Meining A
    Digestion; 2007; 76(3-4):223-8. PubMed ID: 18174685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is impedance pH monitoring superior to the conventional 24-h pH meter in the evaluation of patients with laryngorespiratory symptoms suspected to be due to gastroesophageal reflux disease?
    Ang D; Ang TL; Teo EK; Hsu PP; Tee A; Poh CH; Tan J; Ong J; Fock KM
    J Dig Dis; 2011 Oct; 12(5):341-8. PubMed ID: 21955426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multichannel intraluminal impedance and pH-metry for investigation of symptomatic gastroesophageal reflux disease.
    Weigt J; Mönkemüller K; Peitz U; Malfertheiner P
    Dig Dis; 2007; 25(3):179-82. PubMed ID: 17827936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Esophageal pH-impedance monitoring in patients with therapy-resistant reflux symptoms: 'on' or 'off' proton pump inhibitor?
    Hemmink GJ; Bredenoord AJ; Weusten BL; Monkelbaan JF; Timmer R; Smout AJ
    Am J Gastroenterol; 2008 Oct; 103(10):2446-53. PubMed ID: 18684197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Esophageal pH-impedance monitoring and symptom analysis in GERD: a study in patients off and on therapy.
    Zerbib F; Roman S; Ropert A; des Varannes SB; Pouderoux P; Chaput U; Mion F; Vérin E; Galmiche JP; Sifrim D
    Am J Gastroenterol; 2006 Sep; 101(9):1956-63. PubMed ID: 16848801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Esophageal dysmotility as an important co-factor in extraesophageal manifestations of gastroesophageal reflux.
    Knight RE; Wells JR; Parrish RS
    Laryngoscope; 2000 Sep; 110(9):1462-6. PubMed ID: 10983943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Addition of esophageal impedance monitoring to pH monitoring increases the yield of symptom association analysis in patients off PPI therapy.
    Bredenoord AJ; Weusten BL; Timmer R; Conchillo JM; Smout AJ
    Am J Gastroenterol; 2006 Mar; 101(3):453-9. PubMed ID: 16464226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined multichannel intraluminal impedance and pH-metry: a novel technique to improve detection of gastro-oesophageal reflux literature review.
    Zentilin P; Dulbecco P; Savarino E; Giannini E; Savarino V
    Dig Liver Dis; 2004 Sep; 36(9):565-9. PubMed ID: 15460839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gastroesophageal reflux monitoring: pH (catheter and capsule) and impedance.
    Hong SK; Vaezi MF
    Gastrointest Endosc Clin N Am; 2009 Jan; 19(1):1-22, v. PubMed ID: 19232277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gastroesophageal reflux evaluation in patients affected by chronic cough: Restech versus multichannel intraluminal impedance/pH metry.
    Ummarino D; Vandermeulen L; Roosens B; Urbain D; Hauser B; Vandenplas Y
    Laryngoscope; 2013 Apr; 123(4):980-4. PubMed ID: 23023943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of pH-impedance testing to evaluate patients with suspected extraesophageal manifestations of gastroesophageal reflux disease.
    Malhotra A; Freston JW; Aziz K
    J Clin Gastroenterol; 2008 Mar; 42(3):271-8. PubMed ID: 18223497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of reflux frequency during prolonged multichannel intraluminal impedance and pH monitoring on and off acid suppression therapy.
    Blonski W; Vela MF; Castell DO
    J Clin Gastroenterol; 2009 Oct; 43(9):816-20. PubMed ID: 19398927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined esophageal multichannel intraluminal impedance and pH monitoring after repair of esophageal atresia.
    Fröhlich T; Otto S; Weber P; Pilic D; Schmidt-Choudhury A; Wenzl TG; Köhler H
    J Pediatr Gastroenterol Nutr; 2008 Oct; 47(4):443-9. PubMed ID: 18852636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Catheter-free pH-metry using the Bravo capsule versus standard pH-metry in patients with non-erosive reflux disease (NERD)].
    Mönkemüller K; Neumann H; Fry LC; Kolfenbach S; Malfertheiner P
    Z Gastroenterol; 2009 Apr; 47(4):351-6. PubMed ID: 19358061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of esophageal impedance/pH monitoring in patients with refractory gastroesophageal reflux disease, on and off therapy.
    Pritchett JM; Aslam M; Slaughter JC; Ness RM; Garrett CG; Vaezi MF
    Clin Gastroenterol Hepatol; 2009 Jul; 7(7):743-8. PubMed ID: 19281866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonacid reflux episodes reaching the pharynx are important factors associated with cough.
    Patterson N; Mainie I; Rafferty G; McGarvey L; Heaney L; Tutuian R; Castell D; Johnston BT
    J Clin Gastroenterol; 2009; 43(5):414-9. PubMed ID: 19197196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nocturnal gastric acid breakthrough is not associated with night-time gastroesophageal reflux in GERD patients.
    Weigt J; Kandulski A; Büsch F; Malfertheiner P
    Dig Dis; 2009; 27(1):68-73. PubMed ID: 19439964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of esophageal pH and multichannel intraluminal impedance testing in pediatric patients with suspected gastroesophageal reflux.
    Francavilla R; Magistà AM; Bucci N; Villirillo A; Boscarelli G; Mappa L; Leone G; Fico S; Castellaneta S; Indrio F; Lionetti E; Moramarco F; Cavallo L
    J Pediatr Gastroenterol Nutr; 2010 Feb; 50(2):154-60. PubMed ID: 19680154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical trial: persistent gastro-oesophageal reflux symptoms despite standard therapy with proton pump inhibitors - a follow-up study of intraluminal-impedance guided therapy.
    Becker V; Bajbouj M; Waller K; Schmid RM; Meining A
    Aliment Pharmacol Ther; 2007 Nov; 26(10):1355-60. PubMed ID: 17900268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Esophageal impedance-pH monitoring.
    Sifrim D; Fornari F
    Dig Liver Dis; 2008 Mar; 40(3):161-6. PubMed ID: 18082474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.